Triple-negative breast cancer: Prolactin study may lead to new treatments
Study suggests a prolactin receptor screen could identify triple-negative breast cancer patients with a less aggressive cancer and a better prognosis.
More... |
All times are GMT -7. The time now is 01:33 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021